FilingReader Intelligence
Ono Pharmaceutical revises full-year forecast amid shifting market dynamics
April 28, 2025 at 12:01 PM UTC•By FilingReader AI
Ono Pharmaceutical (TSE:4528) has revised its consolidated financial forecasts for the full year ending March 2025, initially disclosed on October 31, 2024. The company now projects revenue of JPY487.0 billion, a slight increase from the previous forecast of JPY485.0 billion, driven primarily by robust royalty income from Bristol Myers Squibb's OPDIVO.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
TSE:4528•Tokyo Stock Exchange
News Alerts
Get instant email alerts when Ono Pharmaceutical publishes news
Free account required • Unsubscribe anytime